Camden National Corp (CAC) |
|
Camden National Balance Sheet Annual
CAC
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
Balance Sheets
(Annual, GAAP in millions $) |
(Dec 31 2023) 2023 |
(Dec 31 2022) 2022 |
(Dec 31 2021) 2021 |
(Dec 31 2020) 2020 |
(Dec 31 2019) 2019 |
ASSETS |
Cash & cash equivalent |
77.65 |
50.57 |
220.63 |
145.77 |
75.64 |
Cash, Cash Eqvivalents Other |
- |
- |
- |
- |
- |
Marketable Securities |
1,190.78 |
1,259.16 |
1,523.49 |
1,132.81 |
933.07 |
Accounts receivable |
- |
- |
- |
- |
- |
Interest Receivable NO |
- |
- |
- |
- |
- |
Federal Home Loan Bank Stock and Federal Reserve Bank Stock AS |
15.39 |
12.71 |
10.28 |
11.54 |
13.65 |
Loans Receivable Held For Sale Amount |
10.32 |
5.20 |
5.82 |
41.56 |
- |
Inventories |
- |
- |
- |
- |
- |
Other Current Assets |
- |
- |
5.81 |
41.56 |
11.85 |
Total loans net |
4,024.22 |
3,936.51 |
3,364.96 |
3,144.09 |
3,044.68 |
Equipment/Property/Plant Net |
35.05 |
36.02 |
37.78 |
39.88 |
41.84 |
Goodwill net |
94.70 |
94.70 |
94.70 |
94.70 |
94.70 |
Intangibles |
0.97 |
1.56 |
2.19 |
2.84 |
3.53 |
Long-term investments |
101.50 |
99.14 |
97.24 |
94.88 |
92.34 |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net of Valuation Allowance, Liabilities |
- |
- |
- |
- |
16.82 |
Other Assets |
265.42 |
275.42 |
143.29 |
190.67 |
101.41 |
Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
Real Estate Acquired Through Foreclosure FO |
- |
- |
- |
- |
- |
Total Assets |
5,714.51 |
5,671.85 |
5,500.36 |
4,898.75 |
4,429.52 |
LIABILITIES |
Deposits |
4,597.36 |
4,826.93 |
4,608.89 |
4,005.24 |
3,537.74 |
Trading Liabilities, Payables, Accrued Liabilities |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Short-term Debt DE1 |
485.61 |
265.18 |
211.61 |
162.44 |
268.81 |
Other Liabilities |
- |
- |
- |
- |
- |
Interest Bearing Domestic Deposit Brokered |
101.92 |
181.25 |
208.47 |
283.57 |
- |
Taxes Payable |
- |
- |
- |
- |
- |
Servicing, Deferred Liability, Revenue and Advances |
- |
- |
- |
- |
- |
Federal Funds Purchased and Securities Sold under Agreements to Repurchase |
- |
- |
- |
- |
- |
Long-term debt |
44.33 |
44.33 |
44.33 |
59.33 |
59.08 |
Other Borrowings |
- |
- |
- |
- |
10.00 |
Long-term Debt Convertible |
- |
- |
- |
- |
- |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Separate Accounts, Advances |
- |
- |
- |
- |
- |
Accrued Income Taxes, Noncurrent |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Other liabilities, Noncurrent |
5,175.11 |
5,176.24 |
94.23 |
142.42 |
80.47 |
Total Liabilities |
5,219.44 |
5,220.57 |
4,959.06 |
4,369.43 |
3,956.11 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
115.60 |
115.07 |
123.11 |
131.07 |
139.10 |
Retained Earnings / Accumulated Deficit |
481.01 |
462.16 |
424.41 |
377.50 |
340.58 |
Other Equity |
-101.55 |
-125.96 |
-6.23 |
20.74 |
-6.27 |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
495.06 |
451.28 |
541.29 |
529.31 |
473.42 |
Liabilities & Stockholder's
Equity |
5,714.51 |
5,671.85 |
5,500.36 |
4,898.75 |
4,429.52 |
|
|